Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.

Fletcher HA, Filali-Mouhim A, Nemes E, Hawkridge A, Keyser A, Njikan S, Hatherill M, Scriba TJ, Abel B, Kagina BM, Veldsman A, Agudelo NM, Kaplan G, Hussey GD, Sekaly RP, Hanekom WA; BCG study team.

BMC Med. 2016 May 16;14:76. doi: 10.1186/s12916-016-0617-3.

2.

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H; MVA85A 020 Trial Study Team.

Lancet. 2013 Mar 23;381(9871):1021-8.

3.

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

Mansoor N, Scriba TJ, de Kock M, Tameris M, Abel B, Keyser A, Little F, Soares A, Gelderbloem S, Mlenjeni S, Denation L, Hawkridge A, Boom WH, Kaplan G, Hussey GD, Hanekom WA.

J Infect Dis. 2009 Apr 1;199(7):982-90. doi: 10.1086/597304.

4.

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.

Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, Mahomed H, Sadoff J, Hanekom W, Geiter L, Hussey G; South African BCG trial team.

BMJ. 2008 Nov 13;337:a2052. doi: 10.1136/bmj.a2052.

5.

Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.

Mansoor N, Abel B, Scriba TJ, Hughes J, de Kock M, Tameris M, Mlenjeni S, Denation L, Little F, Gelderbloem S, Hawkridge A, Boom WH, Kaplan G, Hussey GD, Hanekom WA.

Clin Immunol. 2009 Mar;130(3):280-9. doi: 10.1016/j.clim.2008.09.006. Epub 2008 Nov 8.

Supplemental Content

Loading ...
Support Center